Get the Stockscreener App
0.4107
1.06%
-0.0044
Promis Neurosciences Inc stock is traded at $0.4107, with a volume of 380.11K.
It is down -1.06% in the last 24 hours and down -17.53% over the past month.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
See More
Previous Close:
$0.4151
Open:
$0.42
24h Volume:
380.11K
Relative Volume:
0.26
Market Cap:
$21.24M
Revenue:
-
Net Income/Loss:
$-563.30K
P/E Ratio:
-2.0576
EPS:
-0.1996
Net Cash Flow:
$-22.23M
1W Performance:
-10.37%
1M Performance:
-17.53%
6M Performance:
-35.83%
1Y Performance:
-64.29%
1-Day Range:
$0.3925
$0.42
1-Week Range:
$0.3925
$0.48
52-Week Range:
$0.38
$1.59
Promis Neurosciences Inc Stock (PMN) Company Profile
Name
Promis Neurosciences Inc
Sector
Industry
Phone
416-847-6898
Address
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.41 | 22.34M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Promis Neurosciences Inc Stock (PMN) Latest News
Will ProMIS Neurosciences Inc. stock recover faster than marketMarket Trend Report & AI Enhanced Trading Signals - newser.com
Can ProMIS Neurosciences Inc. (23J0) stock sustain margin levelsProduct Launch & Comprehensive Market Scan Reports - newser.com
Is ProMIS Neurosciences Inc. stock safe for conservative investors2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock sustain bullish trend into 2025Weekly Profit Report & AI Forecast Swing Trade Picks - newser.com
How ProMIS Neurosciences Inc. stock responds to policy changesJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock sustain uptrend momentumDip Buying & Reliable Entry Point Alerts - newser.com
Detecting price anomalies in ProMIS Neurosciences Inc. with AIEarnings Recap Report & Long-Term Safe Investment Plans - newser.com
ProMIS Neurosciences Inc. stock retracement – recovery analysisEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Short interest data insights for ProMIS Neurosciences Inc.Forecast Cut & Long Hold Capital Preservation Tips - newser.com
Real time scanner hits for ProMIS Neurosciences Inc. explained2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
Should you wait for a breakout in ProMIS Neurosciences Inc.2025 Historical Comparison & Momentum Based Trading Signals - newser.com
What MACD and RSI say about ProMIS Neurosciences Inc.Earnings Miss & Real-Time Volume Trigger Notifications - newser.com
Will ProMIS Neurosciences Inc. price bounce be sustainableJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Is ProMIS Neurosciences Inc. trending in predictive chart modelsJuly 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock beat value stocks2025 Macro Impact & Consistent Income Trade Ideas - newser.com
Is ProMIS Neurosciences Inc. building a consolidation baseTrade Volume Report & Short-Term High Return Ideas - newser.com
Can ProMIS Neurosciences Inc. stock sustain institutional interestJuly 2025 Review & Low Risk High Win Rate Stock Picks - newser.com
Analyzing net buyer seller activity in ProMIS Neurosciences Inc.Weekly Trade Report & Verified Technical Trade Signals - newser.com
Will ProMIS Neurosciences Inc. (23J0) stock outperform global peersJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
Statistical indicators supporting ProMIS Neurosciences Inc.’s strengthWeekly Gains Summary & Smart Investment Allocation Tips - newser.com
ProMIS Neurosciences Advances Alzheimer’s Study with PMN310 - MSN
Promis Neurosciences Inc Stock (PMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):